Meztli Ramos-Garcia

Prof. Dr. Meztli Ramos-Garcia


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
YAYolanda Arias-Córdova
Yolanda Arias-Córdova
JBJorge Ble-Castillo
Jorge Ble-Castillo
CVCarlos García Vázquez
Carlos García Vázquez
VOViridiana Olvera
Viridiana Olvera
Meztli Ramos-GarciaMeztli Ramos-Garcia
Meztli Ramos-Garcia
JMJosé D. Méndez
José D. Méndez
We previously observed beneficial effects of native banana starch (NBS) with a high resistant starch (RS) content on glycemic response in lean and obese participants. Here, we aimed to determine the effects of NBS and high-amylose maize starch (HMS) on glycemic control (GC) and glycemic variability (GV) in patients with type 2 diabetes (T2D) when treatments were matched for digestible starch content. In a randomized, crossover study, continuous glucose monitoring (CGM) was performed in 17 participants (aged 28–65 years, BMI ≥ 25 kg/m2, both genders) consuming HMS, NBS, or digestible maize starch (DMS) for 4 days. HMS and NBS induced an increase in 24 h mean blood glucose during days 2 to 4 (p < 0.05). CONGA, GRADE, and J-index values were higher in HMS compared with DMS only at day 4 (p < 0.05). Yet, NBS intake provoked a reduction in fasting glycemia changes from baseline compared with DMS (p = 0.0074). In conclusion, under the experimental conditions, RS from two sources did not improve GC or GV. Future longer studies are needed to determine whether these findings were affected by a different baseline microbiota or other environmental factors.

28 April 2021 in Foods
Verified
Journal Article
Open access
PDF file
Meztli Ramos-GarciaMeztli Ramos-Garcia
Meztli Ramos-Garcia
JBJorge Ble-Castillo
Jorge Ble-Castillo
CVCarlos García Vázquez
Carlos García Vázquez
Carlos Alfonso Tovilla-ZárateCarlos Alfonso Tovilla-Zárate
Carlos Alfonso Tovilla-Zárate
IJIsela Juarez-Rojop
Isela Juarez-Rojop
JDJuan Diaz-Zagoya
Juan Diaz-Zagoya
The aim of this study was to evaluate the effects of non-nutritive sweeteners (NNS) consumption on energy intake, body weight and postprandial glycemia in healthy and with altered glycemic response rats. Animals on normal diet (ND) or high-fat diet (HFD) were divided to receive NNS (sucralose, aspartame, stevia, rebaudioside A) or nutritive sweeteners (glucose, sucrose) for 8 weeks. The NNS were administered at doses equivalent to the human acceptable daily intake (ADI). A test using rapidly digestible starch was performed before and after treatments to estimate glycemic response. No effects of NNS consumption were observed on energy intake or body weight. Sucrose provoked an increased fluid consumption, however, energy intake, and weight gain were not altered. In ND, no effects of NNS on glycemic response were observed. In HFD, the glycemic response was increased after sucralose and stevia when only the final tolerance test was considered, however, after including the baseline test, these results were no longer significant compared to glucose. These findings provide further evidence suggesting that at the recommended doses, NNS do not alter feeding behavior, body weight or glycemic tolerance in healthy and with altered glycemic rats.

9 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
DMDalila Rubí Mena-Hernández
Dalila Rubí Mena-Hernández
GJGuadalupe Jiménez-Domínguez
Guadalupe Jiménez-Domínguez
JMJosé D. Méndez
José D. Méndez
VOViridiana Olvera
Viridiana Olvera
MMMirian Carolina Martínez-López
Mirian Carolina Martínez-López
JBJorge Ble-Castillo
Jorge Ble-Castillo
This study aimed to evaluate the effect of early time-restricted eating (eTRE) on metabolic markers and body composition in individuals with overweight or obesity. Seventeen subjects completed a randomized, crossover, and controlled clinical trial. Twelve women and five men participated, with a mean age of 25.8 ± 10.0 years and a BMI of 32.0 ± 6.3 kg/m2. The eTRE intervention included 16 h of fasting (3:00 pm to 7:00 am) and 8 h of ad libitum eating (7:00 am to 03:00 pm) (16:8). The trial included four weeks of interventions followed by a four-week washout period. Body weight, waist and hip circumferences, and body composition measurements were taken. Additionally, a venous blood sample was collected for biochemical determinations. In a before–after analysis, eTRE induced a reduction in BW and BMI in women but this was not significant when compared to the control group. eTRE did not modify any other anthropometric measurements, fasting biochemical parameters, glycemic and insulinemic responses, blood pressure, or subjective appetite. In conclusion, eTRE did not induce beneficial effects on the glycemic and lipid metabolisms, body composition, subjective appetite, or blood pressure. These findings may be attributed to the special characteristics of the population and the short intervention period.

21 April 2023 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
CVCarlos García Vázquez
Carlos García Vázquez
JBJorge Ble-Castillo
Jorge Ble-Castillo
YAYolanda Arias-Córdova
Yolanda Arias-Córdova
Meztli Ramos-GarciaMeztli Ramos-Garcia
Meztli Ramos-Garcia
VOViridiana Olvera
Viridiana Olvera
JHJosafat A. Hernández-Becerra
Josafat A. Hernández-Becerra

7 October 2024 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
ZRZeniff Reyes
Zeniff Reyes
VOViridiana Olvera
Viridiana Olvera
Meztli Ramos-GarciaMeztli Ramos-Garcia
Meztli Ramos-Garcia
JMJosé D. Méndez
José D. Méndez
Crystell Guadalupe Guzmán PriegoCrystell Guadalupe Guzmán Priego
Crystell Guadalupe Guzmán Priego
JBJorge Ble-Castillo
Jorge Ble-Castillo
Sucralose stands as the most common non-nutritive sweetener; however, its metabolic effects have sparked significant controversy over the years. We aim to examine the effects of sucralose daily intake on glycemia, subjective appetite, and gut microbiota (GM) changes in subjects with overweight or obesity. In this randomized, crossover, and controlled trial, 23 participants with a body mass index between 25 kg/m2 and 39.9 kg/m2 will be assigned to one of two interventions to receive either sucralose (2 mg/kg/day equivalent to 40% of the acceptable daily intake) or glucose (control) for 4 weeks, each phase separated by a 4-week washout period. The glycemic response will be determined during a meal tolerance test, subjective appetite will be evaluated using a visual analog scale, and GM changes will be analyzed by next-generation sequencing of the bacterial rRNA 16S gene from fecal samples. All measures will be performed before and after intervention periods. We hypothesize that sucralose supplementation induces changes in glycemic response, subjective appetite, and gut microbiota in overweight and obese participants. This protocol was approved by the Ethics Committee of the UJAT (No. 0721) and was registered in the Australian New Zealand Clinical Trials Registry (ACTRN12621001531808).

19 June 2023 in Medicina Clinica
Verified
Journal Article
Closed access
PEPriscila Edith Escobedo-Sánchez
Priscila Edith Escobedo-Sánchez
ICIbis de la Cruz-Hernández
Ibis de la Cruz-Hernández
Meztli Ramos-GarciaMeztli Ramos-Garcia
Meztli Ramos-Garcia
ISIván Sánchez-Yedra
Iván Sánchez-Yedra
CGCarlos García-Vázquez
Carlos García-Vázquez
JBJorge Ble-Castillo
Jorge Ble-Castillo